Cite
APA Citation
Tamburini, E., Gianni, L., Pasini, G., Papi, M., Stocchi, L., Rudnas, B., Affatato, A., Drudi, F., Nicoletti, S., Santelmo, C., Ridolfi, C., Fantini, M., & Tassinari, D. (n.d.). 2109 Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): pooled analysis of randomized clincal trials. European journal of cancer, 51, S365–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000025